ACTA1 and lupus nephritis: In NZB/W F1 lupus-nephritis mice, MMF plus rapamycin improved nephritis, suppressed mTOR/ERK signaling, and reduced TGF-β1, MCP-1, α-SMA, fibronectin and collagen [111].